United States · FDA National Drug Code directory
cevimeline hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43386-999_7e108db5-5292-4f2e-9d10-e15319503898
- Product NDC
- 43386-999
- Form
- CAPSULE
- Composition / generic term
- cevimeline hydrochloride
- Labeler
- Lupin Pharmaceuticals,Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161230
- Source listing expiry
- 20261231
Source-listed ingredients
- CEVIMELINE HYDROCHLORIDE — 30 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
Package details are not available in this snapshot.
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →